In Great Britain, the daily recommended intake of hemp oil has been reduced
[ad_1]
The UK Food Standards Agency (FSA) has recommended that the daily intake of cannabidiol – the non-psychoactive component of cannabis – be reduced from 70 and 10 mg.
The decision was made in mid-October 2023, the FSA said.
As Julio de Carvalho Ponce, a lecturer in forensic science at the University of Winchester, noted in an article for The Conversation, since 2018, when the British Parliament passed a law to legalize cannabidiol (CBD), sales of products containing it have increased rapidly.
Oil, vape pens, coffee and cannabidiol muffins are freely available in the country. As CBD is not a medicinal product in this context, it is regulated by the FSA.
| Photo: bukhta79/Depositphotos |
In 2020, the FSA recommended that the daily intake of CBD should not exceed 70 mg. This limit has now been reduced to 10 mg, to about four drops of 5% CBD oil.
However, 10 mg is only the recommended safe limit.
A person will not be arrested if they use more than 10 mg per day. However, the agency warns that ignoring their advice can lead to long-term health consequences, including damage to the liver and thyroid gland.
Oil with cannabidiol is used for anxiety, depression, disorders of the motor apparatus, the effect of such drugs on patients is still being investigated.
The move to a lower recommended dose comes after several studies have shown that CBD may not be as harmless as previously thought.
To determine how harmful a substance is – or, more precisely, what is the largest safe amount that a person can consume in a given time – scientists test it on animals and then apply a “correction level”.
For example, if in a study using rats a dose of 100 mg per kilogram of body weight is considered the highest dose at which no harm is observed, this would mean that for a 70 kg person the daily intake is 7 g.
However, there are differences in metabolism between species, and humans are potentially more susceptible to harm.
There is also an increased risk of getting too high a dose when taking CBD with other medications, such as ketoconazole (a drug to fight a fungal infection), and even increased absorption when CBD is taken with a fatty meal.
It was on the basis of several animal studies of CBD that indicated similar values that the FSA reduced the recommended dose.
The FSA decision is not a ban. Buy blowout, exceed the new daily limit of cannabidiol by one serving, there will be an opportunity. However, it will be more difficult for a new product with this content to get FSA approval.
We will remind you that in Ukraine, the Committee on the Health of the Nation approved the text of the draft law on medical cannabis adopted in the first reading and recommended that it be brought to the session hall of the Verkhovna Rada.
Read also: What does medical cannabis help and whether it will be legalized in Ukraine in the near future
[ad_2]
Original Source Link
